Roche's Gazyva/Gazyvaro Sbla For SLE Accepted By FDA; Decision Slated For December 2026 RTT News 12:04 Tue, 21 Apr
Correcting and replacing FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus Business Wire (Press Release) 07:53 Tue, 21 Apr
FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus Business Wire (Press Release) 06:02 Tue, 21 Apr
